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Human immunodeficiency virus type 1 (HIV-1) Vpu is phosphorylated at two serine residues (Ser52 and Ser56) present
within the acidic dodecapeptide region of the 54-aa cytoplasmic domain. Previous experiments have shown that Vpu
phosphorylation is critical for the degradation of CD4 in the endoplasmic reticulum. In this study, we carried out
experiments to elucidate the role of individual phosphoacceptor sites in CD4 proteolysis. We show here that acidic
amino acids could not functionally substitute for phosphoserines in Vpu that is capable of inducing the degradation of
CD4. Our studies have further revealed that phosphorylation of either of the two phosphoacceptor sites is not sufficient
to generate a functional Vpu protein. When tested for functional complementation, inactive phosphorylation-proficient
Vpu mutants failed to generate Vpu proteins that had the ability to induce the degradation of Vpu-sensitive glycoproteins.
The failure to complement was not due to assembly defects in the Vpu protein as unphosphorylated Vpu formed
oligomeric complexes in the cell. We also showed that Vpu expression inhibits protein transport in a phosphorylation-
dependent manner. Our studies have thus revealed that both phosphoserines in Vpu are critical participants in a pathway
that leads to the proteolysis of CD4 in the ER and that these phosphoserines should be present on the same subunit
of the Vpu protein. q 1997 Academic Press
INTRODUCTION of Vpu with CD4 sequences at the membrane/cytosolic
interface has resulted in the degradation of ectodomains
The HIV-1 Vpu protein is phosphorylated by the ubiqui- presumably in the ER lumen (Bour et al., 1995; Jabbar,
tous casein kinase 2 at Ser52 and Ser56 (Schubert et al., 1995). The nature and mechanisms of CD4 proteolysis
1994). It is a small transmembrane protein of 16 kDa are not understood at the molecular level. It is clear,
having a 54-aa cytoplasmic domain and is synthesized however, that phosphorylation of the Vpu cytoplasmic
coordinately with gp160 from the same bicistronic mRNA domain represents one of many steps that lead to the
(Cohen et al., 1988; Strebel et al., 1988; Schwartz et al., proteolysis in the ER lumen of ectodomains appended
1990; Jabbar, 1995). Vpu is a multifunctional protein and to CD4 transmembrane and cytoplasmic domains (Schu-
one of its activities is to induce the degradation of CD4 bert and Strebel, 1994; Vincent and Jabbar, 1995; Raja et
or glycoproteins bearing Vpu-responsive elements (Chen al., 1994; Buonocore et al., 1994; Bour et al., 1995; Raja
et al., 1993; Willey et al., 1992a,b, 1994; Vincent et al., and Jabbar, 1996). One of the properties of phosphoryla-
1993; Lenburg and Landau, 1993; Raja et al., 1994; Buo- tion is to increase the acidity in the protein motif that
nocore et al., 1994; Yao et al., 1995; Raja and Jabbar, may participate in varied biological functions. In the case
1996). Vpu-mediated CD4 proteolysis occurs in the endo- of cell surface receptors (e.g., EGFR), the activation step
plasmic reticulum (ER) in a phosphorylation-dependent involves phosphorylation of unique tyrosine residues in
manner (Schubert and Strebel, 1994; Vincent and Jabbar, cytoplasmic domains that recruit SH2-domain-containing
1995; Friborg et al., 1995; Raja and Jabbar, 1996). Analy- proteins (Pawson, 1995). Such a recruitment process re-
sis of Vpu expression has also revealed that the Vpu lays signals to the nucleus through a series of cellular
protein is capable of inducing a secretion block in mam- kinases in the cytoplasm. Mutation of this residue abro-
malian cells (Vincent and Jabbar, 1995). The other activity gates signaling through this pathway. In contrast, there
of Vpu is to enhance the release of virus particles from are instances where acidic amino acid mimetic substitu-
the cell surface of infected cells (Klimkait et al., 1990; tions did not affect the functions of certain serine/threo-
Terwilliger et al., 1989; Yao et al., 1992; Gottlinger et al., nine kinases in signal transduction (Cowley et al., 1994).
1993; Geraghty and Panganiban, 1993; Schubert et al., Schubert et al. (1994) have identified a helix–turn–helix
1996; Schubert and Strebel, 1994; Friborg et al., 1995). motif in the Vpu cytoplasmic domain and this turn motif
Several lines of evidence suggest that the interaction contains a highly acidic dodecapeptide region that in-
cludes phosphoserines at Ser52 and Ser56. It is not
known whether the mere acidic patch of the Vpu cyto-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (216) 444-0512. E-mail: jabbara@cesmtp.ccf.org. plasmic domain would functionally substitute phospho-
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serines in Vpu-mediated degradation reactions in the ER in the vpu gene. Briefly, the primers (250 nM each) were
annealed to template DNA (100 ng) encoding Vpu tolumen.
We demonstrate here that acidic amino acids could generate two DNA fragments (AB or CD) in PCRs using
PFU polymerase (Strategene, San Diego, CA). Gel-puri-not functionally substitute for phosphoserines in Vpu that
induces the degradation of CD4 in the ER. Our studies fied fragments (AB and CD) were combined in the fusion
reaction to obtain full-length Vpu clones after digestionhave further revealed that phosphorylation of either of
the two phosphoacceptor sites is not sufficient to gener- with EcoRI and XbaI. All PCRs were performed in 25 to
30 cycles using a Thermal Cycler. The fusion productsate Vpu activity involved in CD4 proteolysis. Coexpres-
sion of inactive phosphorylated single mutants further were digested with EcoRI and XbaI and cloned into
pcDNA1.showed that both phosphoserines should be present on
the same protein subunit for the generation of a function-
Transfection, immunoprecipitation, and proteinally active Vpu protein in mammalian cells.
quantification
MATERIALS AND METHODS Cells (5 1 105) were seeded onto 35-mm dishes 1 day
prior to transfection and infected with the recombinantCells, viruses, and expression plasmids
vaccinia virus vTF7-3 at an m.o.i. of 10 as described
Recombinant vaccinia virus, vTF7-3, which synthesizes previously (Raja et al., 1993, 1994). At 16 hr posttransfec-
T7 RNA polymerase in HeLa-infected cells, was em- tion, cells were starved for 1 hr in medium lacking methio-
ployed for expression studies (Fuerst et al., 1987). The nine, pulse-labeled with [35S]methionine (DuPont NEN;
genes encoding CD4, HIV envelope proteins, and Vpu 1000 Ci/mmol; 100 mCi/ml) for 30 min, and chased in
proteins were subcloned under control of the T7 pro- medium containing excess unlabeled amino acids. Cell
moter in expression vectors as described previously lysates were prepared in RIPA buffer, immunoprecipi-
(Raja et al., 1993, 1994; Raja and Jabbar, 1996). tated with specific antibodies, and analyzed by SDS–
PAGE. For analysis of sCD4, transfected cells were
Site-directed PCR mutagenesis pulse-labeled with [35S]methionine for 10 min and chased
in unlabeled medium as described above. Both intracel-The following primers were used to introduce muta-
lular and extracellular sCD4 proteins were immunopre-tions in the vpu gene according to the method of Ho et
cipitated with anti-CD4 antibody (T4-4).al. (1989):
To analyze the phosphorylation state of Vpu, plasmids
encoding wt and mutant Vpu proteins were transfected1. 5*CATAACTTACGGTAAATGGC3* A
2. 5*TCTCTGTAGGTAGTTTGTCC3* D into vTF7-3-infected HeLa cells. At 16 hr posttransfection,
3. 5*AGCAGAAGACGAAGGCAATGAGGAAGAAGGAGAAG3* VpuS52,56E-B
cells were washed in PBS and maintained for 90 min in4. 5*CTTCTCCTTCTTCCTCATTGCCTTCGTCTTCTGCT3* VpuS52,56E-C
1 ml of MEM lacking sodium phosphate (Gibco-BRL).5. 5*AGCAGAAGACGAAGGCAATGAGA3* VpuS52E-B
6. 5*TCTCATTGCCTTCGTCTTCTGCT3* VpuS52E-C After this starvation period, the medium was removed
7. 5*TGGCAATGAGGAAGAAGGAGAAG3* VpuS56E-B and replaced with the labeling medium containing [32P]-
8. 5*CTTCTCCTTCTTCCTCATTGCCA3* VpuS56E-C orthophosphate (DuPont NEN, 200 mCi/ml). At the end of
9. 5*AGCAGAAGACGATGGCAATGAGGATGAAGGAGAAG3* VpuS52,56D-B
the labeling period (3 hr), cells were again washed with
10. 5*CTTCTCCTTCATCCTCATTGCCATCGTCTTCTGCT3* VpuS52,56D-C PBS, lysed in RIPA, and immunoprecipitated by aVpu
11. 5*AGCAGAAGACGATGGCAATGAGA3* VpuS52D-B antibody. To assess expression levels of Vpu proteins,
12. 5*TCTCATTGCCATCGTCTTCTGCT3* VpuS52D-C
parallel cultures were simultaneously labeled with [35S]-
13. 5*TGGCAATGAGGATGAAGGAGAAG3* VpuS56D-B
methionine (100 mCi/ml). Detergent lysates were pre-14. 5*CTTCTCCTTCATCCTCATTGCCA3* VpuS56D-C
pared and immunoprecipitated with the anti-Vpu anti-15. 5*AGCAGAAGACAATGGCAATGAGAATGAAGGAGGAG3* VpuS52,56N-B
16. 5*CTTCTCCTTCATTCTCATTGCCATTGTCTTCTGCT3* VpuS52,56N-C body. CD4 and HIV envelope proteins were analyzed on
17. 5*AGCAGAAGACAATGGCAATGAGA3* VpuS52N-B 10% PAGE and Vpu proteins were run on 12% gels. Pro-
18. 5*TCTCATTGCCATTGTCTTCTGCT3* VpuS52N-C
teins were quantified using PhosphorImager (Molecular
19. 5*TGGCAATGAGAATGAAGGAGAAG3* VpuS56N-B
Dynamics).20. 5*CTTCTCCTTCATTCTCATTGCCA3* VpuS56N-C.
Western blot and analysis of Vpu protein complexes
The underlined bases indicate S-to-E, S-to-D, and S-
to-N substitutions at either one or both of the CK-2 phos- Western blot analysis was performed essentially as
described previously (Raja and Jabbar, 1996). Anti-phorylation sites. Primers A and D represent sequences
(5* and 3* ends of the vpu gene) within the plasmid gp120SF2 (1:500) and peroxidase-conjugated anti-goat an-
tibody (1:3000) were used as primary and secondary anti-pCDNA1. Mutation primers B and C were combined with
A and B, respectively, in pairwise combinations to gener- bodies to label E-TC25 in immunoblots. For the analysis
of Vpu proteins, anti-Vpu antibody (1:2000) and peroxi-ate AB and CD gene fragments that were used in the
fusion reaction for the generation of desired mutations dase-conjugated anti-rabbit antibody (1:2000) were
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FIG. 1. Construction of mutant vpu genes and expression of Vpu proteins in HeLa cells. (A) The vpu gene in pcDNA1 was used to introduce
substitutions at the phosphoacceptor sites S52 and S56. The diagram shows salient features of the Vpu protein. The N-terminal hydrophobic amino
acids (27) serve as both ER translocation and transmembrane anchor determinants (ER signal anchor), and the 54-aa Vpu cytoplasmic domain
contains 12 acidic amino acids. The serine residues at positions 52 and 56 within this acidic domain are phosphorylated by casein kinase II
(Schubert et al., 1994). (B) Expression and phosphorylation of Vpu proteins. Plasmids (3 mg each) encoding wt and mutant Vpu proteins were
introduced into vTF7-3-infected HeLa cells. At 16 hr posttransfection, cells were labeled with [35S]methionine or [32P]orthophosphate and lysed in
RIPA. Detergent lysates were immunoprecipitated with the anti-Vpu antibody and resolved on 12.5% SDS–PAGE. 1, VpuS52,56E; 2, VpuS52E; 3,
VpuS56E; 4, VpuS52,56D; 5, VpuS52D; 6, VpuS56D; 7, VpuS52,56N; 8, VpuS52N; 9, VpuS56N; wtVpu.
added onto stripped membranes as described previously lized in sample buffer before being analyzed on 12%
SDS – PAGE (Raja and Jabbar, 1996).(Raja and Jabbar, 1996).
To identify CD4/Vpu – Vpu complexes, the following
protocol was followed. Transfected cells (5 1 105) RESULTS
were pulse-labeled for 30 min in the presence of [35S]-
Expression and phosphorylation of Vpu proteinsmethionine (200 mCi/ml) and suspended in 0.5 ml of
digitonin buffer (1% digitonin, 10 mM Tris – HCl, 150 We performed in vitro site-directed mutagenesis of the
mM NaCl, 1 mM EDTA, 1 mM PMSF, pH 7.5). The cells vpu gene as described under Materials and Methods; the
were then incubated by gentle shaking for 30 min at Vpu proteins are diagrammed in Fig. 1A. For expression
47 on a rotary shaker. The resultant lysates were pre- studies, we introduced in vTF7-3-infected HeLa cells the
cleared by the addition of 5 mg protein-A – Sepharose plasmids harboring wt and mutant vpu genes. Trans-
and by centrifugation (10,000 rpm for 10 min at 47) fected cells were separately labeled with [35S]methionine
after 1 hr of incubation with protein-A (step 1). Anti- (1 hr) and [32P]orthophosphate (3 hr) and lysed in RIPA
body [Vpu or CD4 (3 ml each in 47 ml PBS / 0.1% buffer for immunoprecipitation by an anti-Vpu antibody.
BSA)] – protein-A – Sepharose (5 mg) mixtures were Figure 1B shows the expression and phosphorylation of
prepared separately and the mix was incubated for 1 Vpu proteins in HeLa cells. The expression levels of wt
hr at 47 (step 2). Clarified lysates from step 1 were and mutant Vpu proteins are comparable in transfected
then transferred to fresh eppendorf tubes and 50 ml cells and the phosphorylation state of Vpu protein
of protein-A antibody mix (step 2) was added for incu- revealed some interesting features (Fig. 1B, lanes 1–9
bation for 2 hr with gentle shaking at 47 on a rotary and wtVpu, [35S]Met, and 32P). As expected, cells express-
shaker. At the end of the incubation period, the lysates ing double mutants (VpuS52,56E, VpuS52,56D, and
were spun down in an eppendorf centrifuge for 10 min VpuS52,56N) produced Vpu proteins lacking phosphates
at 10,000 rpm in a cold room. Immune complexes were (Fig. 1B, lanes 1, 4, and 7, [32P]orthophosphate) and a
washed two times with digitonin buffer (0.1% digitonin, phosphorylated Vpu protein was recovered from the ly-
sates of cells expressing the wtvpu gene (Fig. 1B, lane150 mM KCl, and 50 mM Tris – HCl, pH 7.5) and solubi-
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probed with the agp120-specific antibody, and Vpu pro-
teins were analyzed on the same stripped membranes
with aVpu antibody (Fig. 2). The level of E-TC25 was
significantly reduced in cells expressing wtVpu (Fig. 2,
lane 10) compared to that expressed alone (Fig. 2, lane
11). On the other hand, we did not observe any reduction
in the synthesis of E-TC25 in cells transfected with the
mutant vpu genes (Fig. 2, lanes 1–9). We noticed, how-
ever, that Vpu levels were variable for VpuS52,56E (Fig.
2, lane 1), VpuS52E (Fig. 2, lane 2), VpuS56E (Fig. 2, lane
3), and VpuS56D (Fig. 2, lane 6). The reasons for this
FIG. 2. Single and double Vpu mutant proteins are defective in Vpu apparent discrepancy in the Vpu levels are not clear, but
activity that induces a reduction in the steady-state levels of E-TC25. could reflect differences in the ability of anti-Vpu antibody
Plasmids encoding E-TC25 (3 mg each) were transfected with an empty
to recognize mutant Vpu proteins on the immunoblot.vector (6 mg) or pcDNA1 (lane 11) or cotransfected with those (6 mg
More importantly, the immunoblot assay demonstratedeach) expressing wt (lane 10) and mutant Vpu proteins (lanes 1–9)
into HeLa cells. Transfected cells were lysed as described under Mate- that Vpu proteins having phosphoserine at either of the
rials and Methods and 15 mg of each protein was separated by 12% two serine residues were defective in Vpu activity that
SDS –PAGE. Proteins were transferred to nitrocellulose membrane be- induces a reduction in the steady-state levels of E-TC25.
fore being probed with the agp120SF2 antibody. For the detection of
Role of Vpu phosphorylation in the degradation of CD4.Vpu proteins, E-TC25 blots were stripped and the anti-Vpu antibody
We previously used gp160/CD4 hybrid proteins to identifywas added to the blots. All control transfections without Vpu plasmids
received appropriate amounts of pcDNA1 (Figs. 3, 4, 5 and 6) to normal- Vpu-responsive elements (Vincent et al., 1993; Raja et
ize for plasmid concentrations in each transfection. al., 1994; Vincent and Jabbar, 1995; Raja and Jabbar,
1996). CD4 is the natural substrate for Vpu and therefore
we used CD4K3, which is sensitive to Vpu expression inwtVpu). Cells transfected with plasmids encoding single-
HeLa cells (Vincent et al., 1993). As described above, wesubstitution mutants (VpuS52E, VpuS56E, VpuS52D,
used a plasmid ratio of 1:2 (CD4K3:Vpu) and consistentlyvpuS56D) synthesized phosphorylated Vpu proteins (Fig.
failed to recover CD4K3 in immunoprecipitates. This was1B, lanes 2 and 3, 5 and 6) with few exceptions. For
presumably due to rapid degradation of CD4 (Willey etexample, S-to-N substitutions at positions 52 (VpuS52N)
al., 1992a; Vincent et al., 1993). We then reversed theand 56 (VpuS56N) had significantly reduced the effi-
CD4K3 to Vpu ratio to 2:1 and transfected HeLa cells forciency at which phosphates were added, respectively,
pulse–chase analyses. Figure 3 shows the expressionat Ser56 and Ser52 (Figs. 1A and 1B, lanes 8 and 9).
and stability of CD4K3 in transfected cells. When ex-Furthermore, the S56E substitution mutant (VpuS56E)
pressed alone, pulse-labeled CD4K3 was stable for thewas phosphorylated less efficiently, suggesting that glu-
entire chase time with a t12 of more than 5 hr (Fig. 3A,tamic acid (E) at position 56 could interfere with the phos-
lanes 1–4, Fig. 3C). Expression of wtVpu had greatlyphorylation of Ser52 (Fig. 1, lane 3). Conversely, the pres-
reduced the amount of CD4K3 during the pulse time andence of glutamine at Ser52 has little or no influence
CD4K3 underwent a further reduction in amount duringon the phosphorylation of Ser56 (Fig. 1, lane 2). Thus,
the chase period (Fig. 3A, lanes 5–8). Quantitation ofmutational analysis of the phosphoacceptor sites of Vpu
proteins showed that the t12 of CD4K3 was approximatelyrevealed that single amino acid substitutions did not af-
fect the synthesis of Vpu, but had moderate to profound 60 min (Fig. 3C), which is longer than the 12 min reported
effects on Vpu phosphorylation. for CD4 in Vpu-expressing cells (Willy et al., 1992a,b).
The authors used a Vpu to CD4 ratio of 3 in all their
Biological properties of Vpu proteins transfections and therefore the amount of input Vpu also
regulates the t12 of CD4 in transfected cells. More impor-Role of Vpu phosphorylation in the synthesis of Vpu-
tantly, the Vpu proteins defective in the phosphorylationsensitive proteins. We previously demonstrated that the
of one of the serine residues (VpuS52E, VpuS52D,wt Vpu protein reduced the steady-state levels of Vpu-
VpuS52N) were inactive and failed to induce the degra-sensitive gp160/CD4 hybrid proteins (Raja and Jabbar,
dation of CD4K3 (Fig. 3B, lanes 1–12). These mutant1996). We wished to study the effects of Vpu mutations on
proteins showed stability profiles similar to that of CD4K3the stability of E-TC25, a protein that has Vpu-responsive
expressed alone (Fig. 3C). However, anti-CD4 antibodyelements in its transmembrane and cytoplasmic domains
precipitated reduced levels of the CD4K3 protein from(Raja et al., 1994). To this end, we performed transfec-
the lysates of cotransfected cells compared to cells ex-tions of HeLa cells with plasmids encoding E-TC25 alone
pressing CD4K3 alone (compare Fig. 3A, lanes 1–4 toand in combination with each of the vpu genes. Detergent
Fig. 3B, lanes 1–12). Unlike wtVpu-expressing cells,lysates of transfected cells were run on SDS–PAGE, pro-
teins were transferred to nitrocellulose membranes and CD4K3 remained stable during the chase time of 4.5 hr
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lane 1) compared to that of E-TC25 expressed alone (Fig.
4A, lane 2). Importantly, the presence of two vpu plasmids
in cells expressing E-TC25 in pairwise combinations did
not result in reduced levels of E-TC25 (Fig. 4A, lanes 3–
5), suggesting that single phosphorylation-proficient Vpu
mutant proteins cannot functionally complement one an-
other’s defects in the cell. The levels of Vpu proteins are
comparable in all transfected cells (Fig. 4A, lanes 1, 3–
5). To further explore whether any of the Vpu mutant
proteins will have transdominant phenotypes, we trans-
fected cells with plasmids encoding E-TC25 and with
those expressing each of the mutant Vpu proteins in the
presence of wtVpu. As shown in Fig. 4B, E-TC25 levels
were reduced in cells expressing wtVpu (Fig. 4B, lane
2) and the expression of Vpu mutant proteins did not
appreciably interfere with wtVpu activity that induces a
reduction in the levels of E-TC25 (Fig. 4B, lanes 3–6).
However, slightly larger amounts of the E-TC25 protein
were present in triple-transfected cells (Fig. 4B, lanes 3–
6), but never reached the E-TC25 level that was present
in E-TC25-expressing cells (Fig. 4B, lane 1). It is possible
that mixing inactive subunits with active subunits could
generate heterooligomeric Vpu molecules that have the
FIG. 3. Vpu phosphorylation is critical for Vpu activity that induces propensity to interfere with wtVpu activity.
the degradation of CD4. Plasmids (6 mg) encoding CD4K3 were trans- We performed a pulse–chase analysis to provide addi-
fected with 3 mg of pcDNA (A, lanes 1–4) or cotransfected with those
tional evidence for the transdominant phenotype of(3 mg each) expressing wt (A, lanes 5–8) or mutant Vpu proteins (B,
wtVpu and the lack of functional complementation be-lanes 1–12). Transfected cells were pulse-labeled for 15 min with [35S]-
methionine (100 mCi/ml) and chased at the indicated times in medium tween two phosphorylation-proficient Vpu mutants. HeLa
containing unlabeled amino acids and 2.5% serum. Cells were lysed cells were transfected with plasmids expressing E-TC25
in RIPA and immunoprecipitated with the anti-Vpu and anti-CD4 anti- in the presence or in the absence of Vpu proteins (Fig.
bodies before being analyzed in 10% SDS–PAGE. (A) Lanes 1–4,
4C). Pulse-labeled E-TC25 showed some reduction afterCD4K3; lanes 5–8, CD4K3/ wtVpu. (B) Lanes 1–4, CD4K3/ VpuS52E;
3 hr of chase and was stable at 5 hr. In contrast, E-TC25lanes 5–8, CD4K3 / VpuS52D; lanes 9–12, CD4K3 / VpuS52N. (C)
CD4K3 proteins were quantified in a PhosphorImager and are repre- was reduced to undetectable levels after 5 hr of chase
sented as percentages of CD4K3 remaining in the cell. (–h–) CD4K3; in cells expressing wtVpu (Fig. 4C, lanes 4–6) or both
( –s–) CD4K3 / wtVpu; (–j– ) CD4K3 / VpuS52E; (–n–) CD4K3 / wtVpu and VpuS52D (Fig. 4C, lanes 7–9), suggesting
VpuS52D; (–m–) CD4K3 / VpuS52N.
that the activity of wtVpu appears to be dominant and is
consistent with the data of Fig. 4B. Expression of two
Vpu mutant proteins, VpuS52D and VpuS56D, failed toin cells expressing VpuS52E, VpuS52D, and VpuS52N
generate a functional Vpu protein that is capable of in-(lanes Fig. 3A, lanes 5– 8 and Fig. 3B). Moreover, the
ducing the degradation of E-TC25 (Fig. 4C, lanes 10–12).other three single phosphorylation mutants (VpuS56E,
Taken together, these results have demonstrated thatVpuS56D, VpuS56N) were also inactive in CD4 proteoly-
Vpu activity is dependent on the phosphorylation statesis (data not shown). These experiments have demon-
of Vpu and that the two phosphoserines should be pres-strated that singly phosphorylated Vpu proteins are un-
ent on the same subunit of the Vpu protein.able to engage in reactions that lead to the proteolysis
of CD4K3.
Formation of Vpu–CD4/Vpu complexes
Complementation analysis of Vpu proteins
In previous studies we described CD4/Vpu hybrid pro-
teins that were functionally active and indistinguishableHIV-1 Vpu has been shown to be an oligomeric protein
(Maldarelli et al., 1993) and therefore we tested whether from Vpu in their biological activity (Raja and Jabbar,
1996). Chemical cross-linking experiments have shownVpu activity could be restored by plasmids encoding two
mutant Vpu proteins in the same cell. Accordingly, trans- that Vpu is a multimeric protein (Maldarelli et al., 1993).
We therefore used CD4/Vpu hybrid proteins to examinefected cells were analyzed for the levels of E-TC25 ex-
pressed alone and in pairwise combinations with the the ability of Vpu to associate with Vpu sequences in
CD4/Vpu and to assess the role of Vpu phosphorylationmutant vpu genes (Fig. 4A). The wtVpu protein induced
a reduction in the steady-state levels of E-TC25 (Fig. 4A, in complex formation. To this end, cells were transfected
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FIG. 4. (A) Single phosphorylation-proficient Vpu proteins failed to complement and to reduce the expression levels of E-TC25. HeLa cells were
transfected with plasmids (3 mg) expressing E-TC25 alone (lane 2) and those (6 mg each) coding for the wt (lane 1) and mutant Vpu proteins in
pairwise combinations (lanes 3 – 5). Cells were lysed and proteins analyzed in Western blots as described previously (Raja and Jabbar, 1996). (A)
Lane 1, E-TC25 / wtVpu; lane 2, E-TC25; lane 3, E-TC25 / VpuS52E / VpuS56E; lane 4, E-TC25 / VpuS52D / VpuS56D; lane 5, E-TC25 /
VpuS52N / VpuS56N. (B) wtVpu activity is dominant over that of mutant vpu proteins. Experimental protocols are the same as described for A.
Lane 1, E-TC25; lane 2, E-TC25 / wtVpu; lane 3, E-TC25 /wtVpu / VpuS52E; lane 4, E-TC25 /wtVpu / VpuS52D; lane 5, E-TC25 /wtVpu /
VpuS52N; lane 6, E-TC25 /wtVpu / VpuS52,56N. (C) Pulse–chase assay for determination of functional complementation. Plasmids (3 mg) coding
for E-TC25 and the empty vector, pcDNA1 (6 mg), were transfected into HeLa cells (lanes 1–3) or in combination with those (6 mg each) expressing
the wt and mutant Vpu proteins (lanes 4–12). Transfected cells were analyzed for the expression of E-TC25 as described under Materials and
Methods. Lanes 1–3, E-TC25; lanes 4–6, E-TC25 / wtVpu; lanes 7–9, E-TC25 / wtVpu / VpuS52D; lanes 10–12, E-TC25 / VpuS52D / VpuS56D.
with plasmids (3 mg each) expressing Vpu proteins or from mixed lysates, indicating that the formation of CD4/
Vpu–Vpu complexes had occurred in vivo and was notin combination with those expressing CD4–Vpu hybrid
proteins (Fig. 5). We used Vpu (Vpu-tail-specific) and CD4 due to nonspecific protein aggregation during lysis with
digitonin (Fig. 5, lanes 15–17). We recovered rather re-(extracellular domain-specific) antibodies to identify pro-
tein complexes in digitonin lysates. In control single- duced amounts of VpuF in either Vpu or CD4 precipitates
from cotransfected lysates compared to that expressedtransfection experiments, anti-Vpu and anti-CD4 antibod-
ies precipitated, respectively, the Vpu (Fig. 5, lanes 1 and alone (Fig. 5, lanes 3–6 and 12–14). The reasons for
the apparent reduction in CD4–Vpu levels under these2) and CD4/Vpu (VpuF) proteins as expected (Fig. 5, lanes
3 and 4, 10 and 11). No cross-reactivity of heterologous conditions are not clearly understood. It is possible that
CD4–Vpu proteins are recognized rather poorly by anti-proteins with either of the antibodies was observed, indi-
cating the specificity of antibodies to each of the protein Vpu while existing in a complex with the Vpu protein.
Importantly, unphosphorylated Vpu (VpuS52,56N) formeddomains (Fig. 5, lanes 1 –4, 8–11).
complexes with unphosphorylated CD4/Vpu (VpuFP; Fig.More importantly, the anti-CD4 precipitates contained
5, lane 14). These experiments have demonstrated thatboth Vpu and CD4/Vpu proteins from cotransfected cells,
Vpu forms oligomeric complexes in the cell and Vpuindicating strongly that HIV-1 Vpu is capable of forming
phosphorylation is not critical in the process of complexoligomeric complexes with the CD4/Vpu proteins (Fig.
formation.5, lanes 12–14). To test whether these complexes truly
represented a physiologically relevant association be-
Vpu phosphorylation regulates the secretion of sCD4tween these proteins, we mixed lysates from cells trans-
fected individually with either of the two plasmids (Vpu We previously examined the effects of Vpu expression
or CD4/Vpu) and immunoprecipitated them with the anti- in the secretion of gp120 and provided a mechanistic
link between CD4 proteolysis and a secretion block me-CD4 antibody. Anti-CD4 antibody failed to precipitate Vpu
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FIG. 5. wtVpu and unphosphorylated Vpu proteins form oligomeric complexes. HeLa cells were transfected with plasmids (3 mg each) coding for
Vpu and CD4/Vpu proteins alone (lanes 1–4, 8–11, 15–17) or in combination with those expressing both proteins (lanes 5–7, 12–14). Transfected
cells were labeled for 30 min in the presence of [35S]methionine and detergent lysates were made in digitonin buffer as described under Materials
and Methods. Equal portions of lysates were immunoprecipitated with either anti-Vpu (lanes 1–7) or anti-CD4 antibodies (lanes 8–14) and proteins
were analyzed on SDS–PAGE gels. Digitonin lysates from cells expressing CD4/Vpu hybrid proteins (VpuF and VpuFP) were mixed with lysates
from cells expressing wtVpu or VpuS52,56N in vitro and immunoprecipitated with anti-CD4 antibodies (lanes 15–17). Arrows indicate the CD4-Vpu
(top) and Vpu proteins (bottom). VpuF denotes a CD4–Vpu hybrid protein bearing the CD4 extracellular domain and the Vpu protein, CD4E-VpuF;
the corresponding unphosphorylated mutant is referred to as VpuFP (Raja and Jabbar, 1996).
diated by the Vpu protein (Vincent and Jabbar, 1995). In Previous experiments revealed similar phenotypes of the
Vpu mutants in gp120 secretion, suggesting that otherthe present study, a plasmid construct that synthesizes
soluble CD4 (sCD4) was used to examine the role of Vpu determinants in Vpu could regulate Vpu activity in the
secretion process (Vincent and Jabbar, 1995). Impor-phosphorylation in protein secretion in mammalian cells.
Figure 6 shows the expression and secretion rates of tantly, the kinetic profiles are consistent with Vpu effects
in the ER stage of the secretory pathway. Taken together,sCD4 expressed alone and in combination with each of
the Vpu proteins defective in phosphorylation. The sCD4 our results provide evidence that Vpu phosphorylation
is a major regulator of Vpu activity that induces CD4protein was efficiently transported to the cell surface and
secreted into the medium when expressed alone (Fig. proteolysis and a secretion block in mammalian cells.
6A, lanes 9–12). On the other hand, the secretion of
sCD4 was severely defective in cells expressing wtVpu DISCUSSION
(Fig. 6A, lanes 13–16). Analysis of intracellular sCD4 re-
vealed that sCD4 levels were gradually reduced during In the present study, we carried out experiments to
the chase time and correlated with its appearance in elucidate the role of Vpu phosphorylation in CD4 proteol-
the extracellular medium. wtVpu-expressing cells, on the ysis and protein transport in the secretory pathway of
other hand, accumulated sCD4 intracellularly and only mammalian cells. The results of experiments have shown
a small amount of sCD4 was released from the cell. that phosphoserines at positions 52 and 56 in the Vpu
Importantly, the cells expressing Vpu mutants defective cytoplasmic domain are critical in Vpu activity that in-
in phosphorylation (S52,56E, S52,56D) secreted more duces the degradation of CD4. Substitution of either of
sCD4 compared to wtVpu-expressing cells (Fig. 6, lanes the two phosphoserines with an acidic amino acid (D
9–16). However, the reduction in intracellular sCD4 lev- and E) generated Vpu proteins that are as inactive as
els was not as pronounced as in sCD4-transfected cells proteins defective in the phosphorylation of both serine
(Fig. 6C). The kinetics of sCD4 secretion in cells trans- residues. The S-to-D, and S-to-E, substitution at position
fected with the mutants proteins followed very closely 52 or 56 did not interfere with the phosphorylation of
the kinetics of wtVpu up to 40 min, and the levels of serine residues in each of the single mutants. However,
extracellular sCD4 increase in the medium of mutant S-to-N substitutions have significant effects on the phos-
phorylation of nonmutated serine residues at position 52Vpu-transfected cells during long chase times (Fig. 6D).
AID VY 8541 / 6a34$$$103 04-29-97 03:57:19 vira AP: Virology
214 PAUL AND JABBAR
FIG. 6. Vpu phosphorylation is critical for Vpu activity that induces a secretion block. Plasmids (6 mg) encoding sCD4 were transfected into HeLa
cells in the absence (A, lanes 1 –4) or in the presence of those (3 mg each) expressing wt (A, lanes 5–8) and mutant Vpu proteins (B. lanes 1–8).
Transfected cells were pulse-labeled and chased in unlabeled medium at the indicated times. The medium was collected to determine the presence
or absence of sCD4 (A, lanes 9 – 16; B, lanes 9–16) from transfected cells. Detergent lysates were immunoprecipitated with anti-CD4 antibody (T4-
4). Arrows indicate sCD4 in the cell and medium (A and B). Intracellular (C) and extracellular levels (D) of sCD4 were quantified using a PhosphorIm-
ager. (h) sCD4; (j) sCD4 / wtVpu; (m) sCD4 / VpuS52,56E; (n) sCD4 / VpuSS52,56D.
or 56. Thus, the nature of amino acid substitutions at The failure to complement was not due to assembly de-
fects in the Vpu protein as both wt and unphosphorylatedthe phosphoacceptor sites is capable of regulating Vpu
phosphorylation. Double substitutions produced Vpu mu- Vpu were able to form complexes in vivo. The coprecipi-
tation assay using CD4/Vpu proteins could be used totants that were totally devoid of phosphates and there-
fore the serine residues at positions 52 and 56 are the identify amino acids critical in the Vpu oligomerization
process. The mechanisms by which the Vpu protein in-only sites that are utilized by CKII. Importantly, the phos-
phorylation of Vpu at either of the two serine residues is duces the degradation of CD4 or inhibits protein trans-
port are not clearly understood at present. Our studiesnot sufficient to generate Vpu proteins that are active in
the CD4 down-regulation process. Also, acidic amino point to a finer level of regulation at the early stages of
Vpu–CD4 interactions and Vpu phosphorylation plays aacids could not functionally substitute for phosphoser-
ines, suggesting that phosphorylation rather than the central role in the pathway that leads to degradation of
CD4 in the ER (Schubert and Strebel, 1994; Vincent andacidic patch of the Vpu domain is critical in the pathway
that leads to CD4 proteolysis. Jabbar, 1995). Phosphorylation of protein domains has
been shown to be a critical regulator of protein assemblyPrevious cross-linking experiments have revealed that
the Vpu protein has the ability to assemble as an oligo- that transmits signals from the plasma membrane to the
nucleus through kinase cascades (Pawson, 1995). It ismeric protein in vitro (Maldarelli, et al., 1993). We have
shown that single mutants defective in either of the two interesting to note here that Geraghty et al. (1994) have
identified a cellular protein that interacts with Vpu (Vpu-phosphorylation sites failed to functionally complement
each other when expressed together in the same cell. interacting protein, VIP). The nature and consequences
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K. (1993). Human immunodeficiency virus type 1 Vpu protein inducesof VIP–Vpu interactions in the CD4 degradation pathway
degradation of CD4 in vitro: The cytoplasmic domain of CD4 contri-or virus release are not known at present.
butes to vpu sensitivity. J. Virol. 67, 3877–3884.
The serine residues at positions 52 and 56 in the cyto- Cohen, E. A., Terwilliger, E. F., Sodroski, J. G., and Haseltine, W. A.
plasmic domain of Vpu are conserved in the majority of (1988). Identification of a protein encoded by the vpu gene of HIV-
primary HIV isolates (Cohen et al., 1988; Strebel et al., 1. Nature (London) 334, 532–534.
Cowley, A., Paterson, H., Kemp, P., and Marshall, C. J. (1994). Activation1988; Jabbar, 1995). Our experiments revealed that muta-
of MAP kinase is necessary and sufficient for PC12 differentiationtion of either of the two phosphoacceptor sites had pro-
and for transformation of NIH 3T3 cells. Cell 77, 841–852.duced Vpu proteins that are inactive in the CD4 down-
Crise, B., Buonocore, L., and Rose, J. K. (1990). CD4 is retained in
regulation process (this study). The role of CD4 down- the endoplasmic reticulum by the human immunodeficiency virus
regulation in the HIV life cycle is not clearly understood. envelope glycoprotein precursor. J. Virol. 64, 5585–5593.
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H.,However, HIV uses elaborate mechanisms to reduce the
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